Engineering strategies to overcome the current roadblocks in CAR T cell therapy.
Saved in:
| Title: | Engineering strategies to overcome the current roadblocks in CAR T cell therapy. |
|---|---|
| Authors: | Rafiq S; Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA, USA.; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Hackett CS; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Brentjens RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. brentjer@mskcc.org.; Cellular Therapeutics Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA. brentjer@mskcc.org.; Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA. brentjer@mskcc.org. |
| Source: | Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2020 Mar; Vol. 17 (3), pp. 147-167. Date of Electronic Publication: 2019 Dec 17. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1759-4782 |
|---|---|
| DOI: | 10.1038/s41571-019-0297-y |
